Compare MasterCard Inc (MA) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Nuvalent Inc — how do they compare? MasterCard Inc trades at $538.35 (market cap $483.71B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: MasterCard Inc is far larger — about 49.3× Nuvalent Inc's market cap, and MasterCard Inc pays a 0.64% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| MA | NUVL | |
|---|---|---|
Market Cap | $483.71B | $9.81B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Technology |
52-Week High | $598.96 | $123.96 |
52-Week Low | $471.55 | $72.16 |
Enterprise Value | $494.45B | $8.52B |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $538.30, down 0.97% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying. The company demonstrates robust fundamentals with revenue growth from $22.2B in 2022 to $32.8B in 2025, net income margins above 45%, and consistent earnings beats. Recent news highlights AI payment initiatives and expansion into underbanked markets, reinforcing its competitive positioning.
The stock presents a compelling long-term opportunity given its profitability, growth trajectory, and dominant market position, though elevated valuation multiples (P/E 31.68) and competition from emerging payment technologies pose risks. Analyst consensus is strongly bullish with a $634.27 price target, suggesting ~18% upside from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
